MAIA Biotechnology, Inc. Basic Shares Outstanding (Weighted Average)
MAIA Biotechnology, Inc. (MAIA) reported Basic Shares Outstanding (Weighted Average) of 60.79 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 60.79M shares, a 100.64% increase year-over-year.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 45.21M shares, a 63.24% increase year-over-year.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 37.19M shares, a 48.53% increase year-over-year.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 33.20M shares, a 38.95% increase year-over-year.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 32.11M shares, a 44.68% increase from fiscal 2024.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 22.20M shares, a 67.38% increase from fiscal 2023.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 13.26M shares, a 42.95% increase from fiscal 2022.
- MAIA Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 9.28M shares, a 75.75% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 60.79M shares 10-Q · filed 2026-08-10 | 53.09M shares 10-Q · filed 2026-08-10 | 47.73M shares derived: average of 3 quarters · filed 2026-08-10 | 44.10M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 45.21M shares 10-Q · filed 2026-05-11 | 41.20M shares derived: average of 2 quarters · filed 2026-05-11 | 38.54M shares derived: average of 3 quarters · filed 2026-05-11 | 36.48M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 37.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 35.20M shares derived: average of 2 quarters · filed 2026-03-23 | 33.56M shares derived: average of 3 quarters · filed 2026-08-10 | 32.11M shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 33.20M shares 10-Q · filed 2025-11-07 | 31.75M shares derived: average of 2 quarters · filed 2026-08-10 | 30.42M shares 10-Q · filed 2025-11-07 | 29.06M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 30.30M shares 10-Q · filed 2026-08-10 | 29.01M shares 10-Q · filed 2026-08-10 | 27.68M shares derived: average of 3 quarters · filed 2026-08-10 | 26.73M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 27.70M shares 10-Q · filed 2026-05-11 | 26.37M shares derived: average of 2 quarters · filed 2026-05-11 | 25.54M shares derived: average of 3 quarters · filed 2026-05-11 | 24.71M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 25.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 24.47M shares derived: average of 2 quarters · filed 2026-03-23 | 23.71M shares derived: average of 3 quarters · filed 2026-03-23 | 22.20M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 23.89M shares 10-Q · filed 2025-11-07 | 23.05M shares derived: average of 2 quarters · filed 2025-11-07 | 21.25M shares 10-Q · filed 2025-11-07 | 19.80M shares derived: average of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | 22.20M shares 10-Q · filed 2025-08-11 | 19.91M shares 10-Q · filed 2025-08-11 | 18.43M shares derived: average of 3 quarters · filed 2025-08-11 | 17.24M shares derived: average of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | 17.60M shares 10-Q · filed 2025-05-09 | 16.54M shares derived: average of 2 quarters · filed 2025-05-09 | 15.59M shares derived: average of 3 quarters · filed 2025-05-09 | 14.91M shares derived: average of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | 15.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 14.58M shares derived: average of 2 quarters · filed 2025-03-21 | 14.01M shares derived: average of 3 quarters · filed 2025-03-21 | 13.26M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 13.68M shares 10-Q · filed 2024-11-12 | 13.28M shares derived: average of 2 quarters · filed 2024-11-12 | 12.52M shares 10-Q · filed 2024-11-12 | 12.13M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 12.89M shares 10-Q · filed 2024-08-09 | 11.93M shares 10-Q · filed 2024-08-09 | 11.61M shares derived: average of 3 quarters · filed 2024-08-09 | 11.25M shares derived: average of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | 10.98M shares 10-Q · filed 2024-05-14 | 10.97M shares derived: average of 2 quarters · filed 2024-05-14 | 10.70M shares derived: average of 3 quarters · filed 2024-05-14 | 10.08M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 10.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 10.57M shares derived: average of 2 quarters · filed 2024-03-21 | 9.78M shares derived: average of 3 quarters · filed 2024-03-21 | 9.28M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 10.17M shares 10-Q · filed 2023-11-07 | 9.18M shares derived: average of 2 quarters · filed 2023-11-07 | 8.71M shares 10-Q · filed 2023-11-07 | 8.31M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 8.20M shares 10-Q · filed 2023-08-08 | 7.98M shares 10-Q · filed 2023-08-08 | 7.69M shares derived: average of 3 quarters · filed 2023-08-08 | 7.04M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 7.75M shares 10-Q · filed 2023-05-08 | 7.43M shares derived: average of 2 quarters · filed 2023-05-08 | 6.66M shares derived: average of 3 quarters · filed 2023-05-08 | 6.09M shares derived: average of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 7.11M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-24 | 6.11M shares derived: average of 2 quarters · filed 2023-03-24 | 5.53M shares derived: average of 3 quarters · filed 2023-03-24 | 5.28M shares 10-K · filed 2023-03-24 |
| 2021-09-30 | 5.12M shares 10-Q/A · filed 2023-02-06 | 4.75M shares derived: average of 2 quarters · filed 2023-02-06 | 4.67M shares 10-Q/A · filed 2023-02-06 | |
| 2021-06-30 | 4.37M shares 10-Q · filed 2022-08-22 | 4.35M shares 10-Q · filed 2022-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |